Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Hack

Showing results (61-70 of 369) with videos related to

Pageof 37
Sort By:
The Journal of Biological Chemistry|April 5, 1992
Characterization of recombinant C1 inhibitor P1 variantsE Eldering, C C Huijbregts, Y T Lubbers, et al.
Blood|February 9, 2000
Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitorsE H Spaeny-Dekking, A M Kamp, C J Froelich, et al.
Blood|December 1, 1995
Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikreinD M Ravon, F Citarella, Y T Lubbers, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Circulating inflammatory mediators in patients with fever: predicting bloodstream infectionA B Groeneveld, A W Bossink, G J van Mierlo, et al.
Immunology|July 1, 1987
Inactivation of C-1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C-1 inhibitorJ H Nuijens, C C Huijbregts, G M van Mierlo, et al.
Biochemistry|February 18, 1992
Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor BJ D Becherer, J Alsenz, I Esparza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Low molecular weight C1q in systemic lupus erythematosusR Hoekzema, A J Hannema, T J Swaak, et al.
Rheumatology International|January 1, 1988
Complement (C3) metabolism in rheumatoid arthritis in relation to the disease courseA J Swaak, H Han, A van Rooyen, et al.
Blood|August 15, 1997
Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2)F Citarella, A Felici, M Brouwer, et al.
Clinical and Experimental Immunology|November 1, 1993
Neutrophil activation in ivermectin-treated onchocerciasis patientsF L Njoo, C E Hack, J Oosting, et al.
Pageof 37

Showing results (61-70 of 369) with videos related to

Sort By:
Pageof 37
The Journal of Biological Chemistry|April 5, 1992
Characterization of recombinant C1 inhibitor P1 variantsE Eldering, C C Huijbregts, Y T Lubbers, et al.
Blood|February 9, 2000
Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitorsE H Spaeny-Dekking, A M Kamp, C J Froelich, et al.
Blood|December 1, 1995
Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikreinD M Ravon, F Citarella, Y T Lubbers, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Circulating inflammatory mediators in patients with fever: predicting bloodstream infectionA B Groeneveld, A W Bossink, G J van Mierlo, et al.
Immunology|July 1, 1987
Inactivation of C-1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C-1 inhibitorJ H Nuijens, C C Huijbregts, G M van Mierlo, et al.
Biochemistry|February 18, 1992
Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor BJ D Becherer, J Alsenz, I Esparza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1985
Low molecular weight C1q in systemic lupus erythematosusR Hoekzema, A J Hannema, T J Swaak, et al.
Rheumatology International|January 1, 1988
Complement (C3) metabolism in rheumatoid arthritis in relation to the disease courseA J Swaak, H Han, A van Rooyen, et al.
Blood|August 15, 1997
Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2)F Citarella, A Felici, M Brouwer, et al.
Clinical and Experimental Immunology|November 1, 1993
Neutrophil activation in ivermectin-treated onchocerciasis patientsF L Njoo, C E Hack, J Oosting, et al.
Pageof 37